Experience

Celon Pharma S.A.

• Poland
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Head of Metabolic Diseases Research Group

  • Jan 2022 - Present

  ▪ Preclinical Research & Development: Proficient in overseeing and managing preclinical research programs, ensuring adherence to regulatory guidelines and best practices. Skilled in designing and implementing in vivo and in vitro studies, conducting safety and efficacy assessments, and analyzing data for decision-making.▪ Drug Development Life Cycle: Comprehensive knowledge of the drug development process from target identification to clinical trials, including lead optimization, candidate selection, IND preparation, and toxicology studies. Experienced in preparing regulatory submissions and interacting with regulatory authorities.▪ R&D Strategy: Adept at formulating and implementing strategic plans for preclinical research, aligning them with organizational goals and market needs. Expertise in identifying new target opportunities, evaluating therapeutic potential, and assessing the competitive landscape.▪ Team Leadership & Collaboration: Exceptional leadership skills, demonstrated through the successful management of interdisciplinary teams. Skilled in fostering a collaborative and inclusive work environment, encouraging innovative thinking, and nurturing talent to maximize productivity and team performance.▪ Scientific Excellence: Strong scientific background in diabetes, metabolic disorders and medical genetics, with a solid publication record and experience presenting at international conferences. Deep understanding of disease mechanisms, target identification/validation, and the application of cutting-edge technologies in preclinical research. Show less

• Senior Associate Scientist

  • Mar 2017 - Jan 2022

  • Responsible for organizing and running preclinical research of Celon Pharma's innovative bio-product developed by the company.• Grant proposal co-author for Polish National Centre for Research and Development: ''Development of the innovative drug involving GPR40 signalling for neuropathic pain management - its implementation into clinical trials and own entrepreneurship'' (POIR.01.01.01-00-1323/20) - awarded with the funding 2021,• Grant proposal co-author for Polish National Centre for Research and Development: ''GATE: Preclinical and clinical development of an innovative antagonist of GPR40 receptor in type 2 diabetes treatment'' (POIR.01.01.01-00-0334/17-00) - awarded with the funding 2017.• Preparing the Investigational Medicinal Product Dossier (IMPD) and Investigator's Brochure accordingly to GCP guidelines for clinical trial ''Clinical development of an innovative antagonist of GPR40 receptor in type 2 diabetes treatment'' - Phase 1a/b completed, Phase 2a ongoing.• Lead inventor and co-author of patent application ''Human Fibroblast Growth Factor 1 (FGF-1) muteins, their dimers and applications'' - submitted.• Project co-management and Lead Scientist on the project ''FAIND: A new diabetes treatment using an innovative FGF1 protein analogue'' (POIR.04.01.04-00-0117/15).• Responsible for in vitro studies, planning and conducting experiments, and preparing reports, which include up-to-date information from scientific journals.• Planning in vivo (efficacy, tumorigenesis, toxicology, pharmacokinetics) studies and analyzing their outcomes.• Ensure all the research compliance with international policies and guidelines.• Review the global pharmaceutical market to find potential new targets and treatments.• Searching for new collaborators on the international market to improve the company's ability to conduct more advanced in vivo research.• Participating in various Drug Development and Clinical trials international meetings. Show less



The University of Edinburgh

• United Kingdom
• Research Services
• 700 & Above Employee

• PHD Graduate Student

  • Sep 2009 - Jun 2016

  • Expression and purification of recombinant proteins using bacterial and Drosophila melanogaster, AKTApurifier system, SEC, affinity chromatography. • Molecular cloning. • Protein and DNA analysis, BLAST, ClustalW, DeepView. • PCR, RT-PCR, real-time-PCR, Nothern blot. • Western blot, ELISA, immunoprecipitation, pull-down. • Cell lines, cell transfection, siRNA. • Using Drosophila melanogaster and Zebrafish as a model for human diseases, microinjections, and morpholine. • Light, immunofluorescence and confocal microscopy. • Preparing grant and project proposals. • Analysis of scientific publications. • Preparing manuscripts for publication. • Day-to-day supervision of other students, undergraduate students and technicians. Show less